#GynCSM Transcript
Healthcare social media transcript of the #GynCSM hashtag.
– ().
See #GynCSM Influencers/Analytics.
| Profile | Tweet |
|---|---|
 | NCI Cancer Stats @NCICancerStats Localized #VulvarCancer has an 86.4% 5-year relative survival rate: https://t.co/HzuWhs4OKh #GynCSM https://t.co/KnegiZU6II |
 | Dee Sparacio @womenofteal RT @gyncsm: The #gyncsm (GYNecologic Cancer Social Media) chat will get started in a few minutes! |
 | GYN Cancer | #GYNCSM @gyncsm Welcome to #gyncsm - a passionate community of gynecologic cancer survivors, caregivers, advocates and health care providers. |
| Dee Sparacio @womenofteal RT @gyncsm: Welcome to #gyncsm - a passionate community of gynecologic cancer survivors, caregivers, advocates and health care providers. |
| GYN Cancer | #GYNCSM @gyncsm Our co-moderators are @womenofteal @btrfly12 #gyncsm |
| GYN Cancer | #GYNCSM @gyncsm Our health care moderators are @ShannonWestin @DrMarkham @journeycancer and our mental health moderator @DrBeckerSchutte #gyncsm |
| GYN Cancer | #GYNCSM @gyncsm We start out with 10 min of introductions - Please take a moment to introduce yourself. #gyncsm |
 | Christina Lizaso @btrfly12 RT @gyncsm: Welcome to #gyncsm - a passionate community of gynecologic cancer survivors, caregivers, advocates and health care providers. |
| Dee Sparacio @womenofteal RT @gyncsm: We start out with 10 min of introductions - Please take a moment to introduce yourself. #gyncsm |
| Christina Lizaso @btrfly12 RT @gyncsm: You can read over tonight’s #gyncsm topics before we get started https://t.co/DgGHa3HBjy |
 | Rick Boulay,MD @journeycancer RT @gyncsm: Welcome to #gyncsm - a passionate community of gynecologic cancer survivors, caregivers, advocates and health care providers. |
| Dee Sparacio @womenofteal Dee here! Dx #ovca Stage3B 2005, OC research advocate, blogger & co-moderator #gyncsm |
 | Shereese Maynard, MS; MBA 😷 She/Her @ShereeseMayMba Hello all. I'm Shereese, healthcare strategist, writer, & speaker, living in Maryland. Thanks for the invite. #gyncsm https://t.co/1z6xWKtI8u |
| Rick Boulay,MD @journeycancer Hello everyone. Rick Boulay Gyn Onc fresh from New Orleans SGO Meeting. #gyncsm |
| Dee Sparacio @womenofteal @ShereesePubHlth Hi There Sheresse. Glad you can join us #gyncsm |
| Christina Lizaso @btrfly12 Christina Lizaso – passionate re: community engagement and cancer. I’ll be moderating as @gyncsm today. #gyncsm |
| GYN Cancer | #GYNCSM @gyncsm If you prefer to listen only during the chat, we'd love for you to tweet "#gyncsm" when you join just to let us know you are here. #gyncsm |
| Dee Sparacio @womenofteal @journeycancer Can't wait to hear your insights. #gyncsm |
 | Jenny Mueller MD @JennyMueller_ Jenny Mueller here! I am a gyn oncologist and happy to be a part of tonight's chat! #gyncsm |
| Dee Sparacio @womenofteal RT @gyncsm: If you prefer to listen only during the chat, we'd love for you to tweet "#gyncsm" when you join just to let us know you are here. #gyncsm |
| Shereese Maynard, MS; MBA 😷 She/Her @ShereeseMayMba RT @NCICancerStats: Localized #VulvarCancer has an 86.4% 5-year relative survival rate: Localized #VulvarCancer has an 86.4% 5-year relative survival rate: https://t.co/HzuWhs4OKh #GynCSM https://t.co/KnegiZU6II |
 | Clearity Foundation @ClearityFnd Clearity Foundation here! We are a non-profit based in #SanDiego dedicated to helping ovarian cancer patients and their families make better informed treatment decisions. #gyncsm |
| GYN Cancer | #GYNCSM @gyncsm Pls continue intro's & welcomes - we'll start in w/ the "ground rules" :) #gyncsm |
| Dee Sparacio @womenofteal @JennyMueller_ Thanks for joining us Jenny. #gyncsm |
| GYN Cancer | #GYNCSM @gyncsm The #gyncsm chat promotes community in a public forum. Learn more about risks/benefits: https://t.co/TipZUv1jQy |
 | Michele E. Collins @Michele_w_1_L Not sure if I’m doing this right. Michele here. 3 year #ovca survivor. Stage 2B HGS. #gyncsm |
 | Debra Hallisey @advocatemomdad Deb here from @advocatemomdad #gyncsm |
 | Inspire @InspireIsHealth Hello to #gyncsm, John Novack here from Inspire. |
| Dee Sparacio @womenofteal @ClearityFnd Welcome. Thanks for the great tweets from the meeting. #gyncsm |
| Dee Sparacio @womenofteal Today's chat is solely informational & not a substitute for speaking w/ a doctor who's familiar w/your medical needs & history. #gyncsm |
| Rick Boulay,MD @journeycancer @womenofteal That and a quarter will get you...#gyncsm |
| Shereese Maynard, MS; MBA 😷 She/Her @ShereeseMayMba @journeycancer Hi Doc. I've just returned from NOLA myself. i was attending #HITmc as a speaker. I hope your weather was good. #gyncsm |
| Dee Sparacio @womenofteal Remember- Twitter is an open social network & posts are public.Use a DM to exchange email addresses/personal info #gyncsm |
 | Suzie Siegel @SuzieSiegel I'm a volunteer for @SarcomaAlliance & @CureSarcoma. I think this is my 10th time to attend #SGOmtg. I use a bowl of chocolate to try to lure over #gyncsm professionals. https://t.co/9AKflwnBOh |
| Clearity Foundation @ClearityFnd RT @womenofteal: Today's chat is solely informational & not a substitute for speaking w/ a doctor who's familiar w/your medical needs & history. #gyncsm |
| GYN Cancer | #GYNCSM @gyncsm #gyncsm is not a forum for medical advice. Resources and referrals are provided solely for information and convenience. |
 | Georgia @_GeorgiaHurst RT @EMBOSU: Bummed to miss the #gyncsm chat tonight, but hope others can join! #SGOmtg was packed full of interesting topics, and I tried to tweet many of the talks while I was there (feel free to dig around my past tweets for highlights)! #endcancer #bcsm #crcsm #gencsm #gcchat #ACMGMtg18 https://t.co/wmZXLf3MZU |
| GYN Cancer | #GYNCSM @gyncsm We also welcome all those “listening in”. You can always tweet us or email us with questions/comments after the chat is over. #gyncsm |
| Dee Sparacio @womenofteal #gyncsm community is here 2 support and inform survivors, med workers & loved ones w/ gyn cancer interest |
| Dee Sparacio @womenofteal #gyncsm https://t.co/DefIyH6hjm |
| GYN Cancer | #GYNCSM @gyncsm Tonight we will discuss research presented at the #SGOmtg (Society of Gynecologic Oncology Annual Meeting) #gyncsm |
| Shereese Maynard, MS; MBA 😷 She/Her @ShereeseMayMba RT @gyncsm: #gyncsm is not a forum for medical advice. Resources and referrals are provided solely for information and convenience. |
| Georgia @_GeorgiaHurst Good evening to all, glad to be here... #gyncsm |
| Dee Sparacio @womenofteal #gyncsm https://t.co/KHcKNB2hdP |
| GYN Cancer | #GYNCSM @gyncsm As moderator, I'll introduce new Topics with T1, T2... Pls include corresponding T# at front of answer -hard to remember but helpful #gyncsm |
| Dee Sparacio @womenofteal @IAmGeorgiaHurst Waving Hello Georgia #gyncsm |
| Georgia @_GeorgiaHurst RT @gyncsm: Tonight we will discuss research presented at the #SGOmtg (Society of Gynecologic Oncology Annual Meeting) #gyncsm |
| Dee Sparacio @womenofteal RT @gyncsm: As moderator, I'll introduce new Topics with T1, T2... Pls include corresponding T# at front of answer -hard to remember but helpful #gyncsm |
| Georgia @_GeorgiaHurst RT @womenofteal: #gyncsm community is here 2 support and inform survivors, med workers & loved ones w/ gyn cancer interest |
| Shereese Maynard, MS; MBA 😷 She/Her @ShereeseMayMba RT @gyncsm: As moderator, I'll introduce new Topics with T1, T2... Pls include corresponding T# at front of answer -hard to remember but helpful #gyncsm |
| Christina Lizaso @btrfly12 RT @gyncsm: Tonight we will discuss research presented at the #SGOmtg (Society of Gynecologic Oncology Annual Meeting) #gyncsm |
 | Dr. Grace Campbell, PhD, MSW, RN, CRRN, FARN @GraceCampbellRN I'm a rehabilitation nurse interested in maximizing women's function and quality of life during and after treatment. Wasn't able to attend #SGOmtg and am eager to hear updates. #gyncsm |
| Rick Boulay,MD @journeycancer @IAmGeorgiaHurst Welcome back to twitter Georgia!#gyncsm |
| Dee Sparacio @womenofteal @GraceCampbellRN Welcome Grace. #gyncsm |
| Suzie Siegel @SuzieSiegel It's so important for gyn oncs to be comfortable with #doxorubicin because it's often being paired with #olaratumab now in #leiomyosarcoma. #gyncsm https://t.co/lnrdJDQc9A |
| GYN Cancer | #GYNCSM @gyncsm See this link for more information on today’s #gyncsm topics: https://t.co/DgGHa3HBjy |
| Georgia @_GeorgiaHurst RT @gyncsm: The #gyncsm chat promotes community in a public forum. Learn more about risks/benefits: The #gyncsm chat promotes community in a public forum. Learn more about risks/benefits: https://t.co/TipZUv1jQy |
| Dee Sparacio @womenofteal #gyncsm https://t.co/aagxWo0A3B |
 | Jennifer N Stall, MD @JNStallMD @gyncsm Hi everyone! Excited to join this evening! I am a gyn pathologist from Minneapolis-StPaul. #gyncsm |
| Rick Boulay,MD @journeycancer @SuzieSiegel @SarcomaAlliance @CureSarcoma Thank you for your advocacy. And chocolate. #gyncsm |
| Dee Sparacio @womenofteal @A2Path @gyncsm Hi Jennifer, Thanks so much for joining us. #gyncsm |
| GYN Cancer | #GYNCSM @gyncsm We'll start with key studies in #cervicalcancer, #ovariancancer and #uterinecancer then address gyn cancers overall plus take participant questions along the way. #gyncsm |
| Dee Sparacio @womenofteal #gyncsm https://t.co/zkGcqnjMCK |
| GYN Cancer | #GYNCSM @gyncsm T1A: What were the results of the study comparing minimally invasive surgery (MIS) w/ radical hysterectomy in early cervical cancer. Will the results change practice? #gyncsm |
| Shereese Maynard, MS; MBA 😷 She/Her @ShereeseMayMba RT @gyncsm: T1A: T1A: What were the results of the study comparing minimally invasive surgery (MIS) w/ radical hysterectomy in early cervical cancer. Will the results change practice? #gyncsm |
| Dee Sparacio @womenofteal #gyncsm https://t.co/QaxL51iPaa |
| Rick Boulay,MD @journeycancer @A2Path @gyncsm Welcome Jen #gyncsm |
| Georgia @_GeorgiaHurst RT @gyncsm: T1A: T1A: What were the results of the study comparing minimally invasive surgery (MIS) w/ radical hysterectomy in early cervical cancer. Will the results change practice? #gyncsm |
| Georgia @_GeorgiaHurst RT @womenofteal: #gyncsm https://t.co/zkGcqnjMCK |
| Rick Boulay,MD @journeycancer RT @gyncsm: T1A: T1A: What were the results of the study comparing minimally invasive surgery (MIS) w/ radical hysterectomy in early cervical cancer. Will the results change practice? #gyncsm |
| Georgia @_GeorgiaHurst RT @womenofteal: #gyncsm https://t.co/QaxL51iPaa |
| Clearity Foundation @ClearityFnd RT @gyncsm: T1A: T1A: What were the results of the study comparing minimally invasive surgery (MIS) w/ radical hysterectomy in early cervical cancer. Will the results change practice? #gyncsm |
 | Kathleen Maxian @KathleenMaxian Hi eveyone, #gyncsm happy to be her for tonight's chat! |
| Dee Sparacio @womenofteal #gyncsm Dr Dood reported this from the meeting https://t.co/rOGxo4lyPm |
| Christina Lizaso @btrfly12 T1A: minimally invasive was inferior in this particular study - making a tough decision tougher for docs and patients... #gyncsm |
| Shereese Maynard, MS; MBA 😷 She/Her @ShereeseMayMba T1 "Disease-free survival following minimally invasive procedures significantly lagged behind radical hysterectomies done by open laparotomy," -Pedro T. Ramirez, MD. I found this fascinating. #gyncsm |
| Dee Sparacio @womenofteal @KathleenMaxian Happy you are joining us too. #gyncsm |
| Jenny Mueller MD @JennyMueller_ T1A: Surprising results for our community to digest #gyncsm |
| Georgia @_GeorgiaHurst RT @btrfly12: T1A: T1A: minimally invasive was inferior in this particular study - making a tough decision tougher for docs and patients... #gyncsm |
| Georgia @_GeorgiaHurst RT @womenofteal: #gyncsm Dr Dood reported this from the meeting https://t.co/rOGxo4lyPm |
| Christina Lizaso @btrfly12 RT @ShereesePubHlth: T1 "Disease-free survival following minimally invasive procedures significantly lagged behind radical hysterectomies done by open laparotomy," -Pedro T. Ramirez, MD. I found this fascinating. #gyncsm |
| Dee Sparacio @womenofteal @JennyMueller_ T1A Were reasons proposed for the large difference ? #gyncsm |
| GYN Cancer | #GYNCSM @gyncsm T1B: What other #cervicalcancer studies were of interest to you from #SGOmtg? #gyncsm |
| Dee Sparacio @womenofteal #gyncsm https://t.co/z4eMYzyhb0 |
| Shereese Maynard, MS; MBA 😷 She/Her @ShereeseMayMba RT @gyncsm: T1B: T1B: What other #cervicalcancer studies were of interest to you from #SGOmtg? #gyncsm |
 | Shannon Westin, MD, MPH, FASCO @ShannonWestin Hello all! Gyn Onc from @mdandersonnews! #gyncsm |
| Rick Boulay,MD @journeycancer @JennyMueller_ In hindsight I’m not that surprised. I think when we lose our tactile sense we miss things. #gyncsm |
| Dee Sparacio @womenofteal @ShannonWestin @MDAndersonNews Hello there Shannon. #gyncsm |
 | Rie Lopez, MPH (she/her) @RieOfLetters Trying to subtly sneak in to the #gyncsm chat. Pay no attention to the Rie behind the blades of grass... https://t.co/lkohvt4Eo7 |
| Dee Sparacio @womenofteal Makes sense. #gyncsm https://t.co/fUIGHJURUw |
| Christina Lizaso @btrfly12 from the patient viewpoint, seems so tough thinking your cancer is minimal/caught early but still need to be fully opened up #gyncsm |
| Jenny Mueller MD @JennyMueller_ T1A: some suggested uterine manipulator use (not assessed in the study), also discussed immature data, early stopping. #gyncsm |
| Shereese Maynard, MS; MBA 😷 She/Her @ShereeseMayMba RT @btrfly12: from the patient viewpoint, seems so tough thinking your cancer is minimal/caught early but still need to be fully opened up #gyncsm |
| Dee Sparacio @womenofteal #gyncsm https://t.co/70xRhfKn6A |
| Rick Boulay,MD @journeycancer Any reasons would be speculation. But I think we get bigger tissue margins with open surgery. #gyncsm https://t.co/mEvZPrtpun |
 | Tobey @BRCAinfo Huffing & puffing I made it. Sorry I’m late. Hi all 👋 #gyncsm |
| Dee Sparacio @womenofteal @JennyMueller_ Thanks . Was stopping early because of the differences seen? #gyncsm |
| Shannon Westin, MD, MPH, FASCO @ShannonWestin @JennyMueller_The data safety monitoring committee (filled with GYN ONCS) said the study should be stopped #gyncsm |
| Dee Sparacio @womenofteal @BRCAinfo Hi there Tobey. #gyncsm |
| Rie Lopez, MPH (she/her) @RieOfLetters Going on right now, an important #gyncsm chat. Feel free to join in or lurk. 😊 https://t.co/vzSldBXCCL |
| Shannon Westin, MD, MPH, FASCO @ShannonWestin @womenofteal @JennyMueller_ Yes - because of worse outcome in the MIS group #gyncsm |
| Dee Sparacio @womenofteal #gyncsm https://t.co/ydFNxNcyCA |
| Shannon Westin, MD, MPH, FASCO @ShannonWestin @BRCAinfo - good to see you Tobey! #gyncsm |
| Jennifer N Stall, MD @JNStallMD @journeycancer @JennyMueller_ T1A: was there any difference by histologic subtype? Or pattern of invasion? #gyncsm |
| GYN Cancer | #GYNCSM @gyncsm T2A: Several studies used targeted therapies to treat #ovariancancer - Which results stood out for you? Were side effects critical in any of the studies? #gyncsm |
| Rie Lopez, MPH (she/her) @RieOfLetters @BRCAinfo Hi Tobey! Always great to see you. 😀 #gyncsm |
| Christina Lizaso @btrfly12 RT @RieOfLetters: Going on right now, an important #gyncsm chat. Feel free to join in or lurk. 😊 https://t.co/vzSldBXCCL |
| Dee Sparacio @womenofteal #gyncsm https://t.co/Y9GBeiV3Cd |
| Jenny Mueller MD @JennyMueller_ T1A: @shannonwestin Yes - important safety component of this study. #gyncsm |
| Georgia @_GeorgiaHurst RT @womenofteal: Makes sense. #gyncsm https://t.co/fUIGHJURUw |
| Rick Boulay,MD @journeycancer This speaks volumes. ⬇️ #gyncsm https://t.co/mDmsFfu0Z0 |
| Shereese Maynard, MS; MBA 😷 She/Her @ShereeseMayMba RT @gyncsm: T2A: T2A: Several studies used targeted therapies to treat #ovariancancer - Which results stood out for you? Were side effects critical in any of the studies? #gyncsm |
| Georgia @_GeorgiaHurst RT @ShereesePubHlth: T1 "Disease-free survival following minimally invasive procedures significantly lagged behind radical hysterectomies done by open laparotomy," -Pedro T. Ramirez, MD. I found this fascinating. #gyncsm |
| Dee Sparacio @womenofteal RT @journeycancer: This speaks volumes. ⬇️ #gyncsm https://t.co/mDmsFfu0Z0 |
| Georgia @_GeorgiaHurst RT @womenofteal: #gyncsm https://t.co/Y9GBeiV3Cd |
| Georgia @_GeorgiaHurst RT @gyncsm: T2A: T2A: Several studies used targeted therapies to treat #ovariancancer - Which results stood out for you? Were side effects critical in any of the studies? #gyncsm |
| Christina Lizaso @btrfly12 T1A: The MIS comparison study makes me think about how long does it take studies like this to trickle out into what happens in practice... #gyncsm |
| Shannon Westin, MD, MPH, FASCO @ShannonWestin T2A: The #PARPi combinations are very exciting - responses and improved outcomes regardless of #BRCA status are encouraging #gyncsm |
| Dee Sparacio @womenofteal #gyncsm https://t.co/Ol7vjSqhn8 |
| Christina Lizaso @btrfly12 @ShannonWestin That is great to hear because so many are #BRCA negative and wishing more treatment options would be available for them. #gyncsm |
| Rie Lopez, MPH (she/her) @RieOfLetters RT @ShannonWestin: T2A: T2A: The #PARPi combinations are very exciting - responses and improved outcomes regardless of #BRCA status are encouraging #gyncsm |
| Rick Boulay,MD @journeycancer @btrfly12 It’s scary. We need to think of these and stdy these as new procedures. Not just same procedure, new technology. #gyncsm |
| Georgia @_GeorgiaHurst RT @womenofteal: #gyncsm https://t.co/Ol7vjSqhn8 |
| Georgia @_GeorgiaHurst RT @ShannonWestin: T2A: T2A: The #PARPi combinations are very exciting - responses and improved outcomes regardless of #BRCA status are encouraging #gyncsm |
| GYN Cancer | #GYNCSM @gyncsm Any other #ovca studies of note? #gyncsm |
| Rick Boulay,MD @journeycancer RT @ShannonWestin: T2A: T2A: The #PARPi combinations are very exciting - responses and improved outcomes regardless of #BRCA status are encouraging #gyncsm |
| Shannon Westin, MD, MPH, FASCO @ShannonWestin @btrfly12 Yes!! another way to get these successful drugs to all patients! #gyncsm |
| Christina Lizaso @btrfly12 RT @journeycancer: @btrfly12 It’s scary. We need to think of these and stdy these as new procedures. Not just same procedure, new technology. #gyncsm |
 | DaveisAliveAndKickn @AliveAndKicknDD Foundation for #lynchsyndrome and home to the HEROIC patient driven registry #gyncsm |
| Shannon Westin, MD, MPH, FASCO @ShannonWestin T2a: The combo of everolimus & letrozole was quite successful in #endometrialcancer - this is the 2nd study to demonstrate this #gyncsm |
| Shereese Maynard, MS; MBA 😷 She/Her @ShereeseMayMba RT @btrfly12: @ShannonWestin That is great to hear because so many are #BRCA negative and wishing more treatment options would be available for them. #gyncsm |
| Dee Sparacio @womenofteal #gyncsm https://t.co/5rA0sZchTr |
| Dee Sparacio @womenofteal #gyncsm https://t.co/TCQjh12BuA |
| Christina Lizaso @btrfly12 @ShannonWestin Some years it feels like not much progress. Nice to see targeted therapies with successful results in various gyn cancers. #gyncsm |
| Rick Boulay,MD @journeycancer RT @ShannonWestin: T2a: T2a: The combo of everolimus & letrozole was quite successful in #endometrialcancer - this is the 2nd study to demonstrate this #gyncsm |
| Tobey @BRCAinfo RT @ShannonWestin: T2A: T2A: The #PARPi combinations are very exciting - responses and improved outcomes regardless of #BRCA status are encouraging #gyncsm |
| GYN Cancer | #GYNCSM @gyncsm T3: Which studies presented at the meeting will impact treatment of women with #endometrialcancer #uterinecancer #sarcoma? #gyncsm |
| Tobey @BRCAinfo RT @btrfly12: @ShannonWestin That is great to hear because so many are #BRCA negative and wishing more treatment options would be available for them. #gyncsm |
| Shannon Westin, MD, MPH, FASCO @ShannonWestin @btrfly12 Really is satisfying - I think we will see more cool stuff at ASCO #gyncsm |
| Dee Sparacio @womenofteal #gyncsm https://t.co/noz3ZWcIfq |
| Kathleen Maxian @KathleenMaxian This is good news, this patient population is desperate for new treatments! #gyncsm https://t.co/LQvXX3GLuz |
| Clearity Foundation @ClearityFnd T2: From our Scientific Director, Dr. Deb Zajchowski, “Exciting preliminary results for PARP inhibitors combined with immune checkpoint inhibitors — particularly in platinum-resistant patients.” #gyncsm https://t.co/t8ZAnUU9zE |
| Suzie Siegel @SuzieSiegel If any of my #sarcoma ppl are on this chat, remember that the others are talking about carcinomas. #gyncsm |
| Rick Boulay,MD @journeycancer This was a standout study in a combination I’ve not heard of. #gyncsm https://t.co/uYn3joJYFj |
| Dee Sparacio @womenofteal #gyncsm https://t.co/pH1EhVd9uW |
| Jenny Mueller MD @JennyMueller_ I agree @btrfly12 this year's meeting presented promising data, very exciting #gyncsm |
| Christina Lizaso @btrfly12 RT @ClearityFnd: T2: T2: From our Scientific Director, Dr. Deb Zajchowski, “Exciting preliminary results for PARP inhibitors combined with immune checkpoint inhibitors — particularly in platinum-resistant patients.” #gyncsm https://t.co/t8ZAnUU9zE |
| Christina Lizaso @btrfly12 RT @journeycancer: This was a standout study in a combination I’ve not heard of. #gyncsm https://t.co/uYn3joJYFj |
| Georgia @_GeorgiaHurst RT @womenofteal: #gyncsm https://t.co/pH1EhVd9uW |
| Rick Boulay,MD @journeycancer RT @ClearityFnd: T2: T2: From our Scientific Director, Dr. Deb Zajchowski, “Exciting preliminary results for PARP inhibitors combined with immune checkpoint inhibitors — particularly in platinum-resistant patients.” #gyncsm https://t.co/t8ZAnUU9zE |
| Rie Lopez, MPH (she/her) @RieOfLetters Excited to see these types of findings in more than one #research study. Hoping for continued progress! #gyncsm https://t.co/5X9ejWHHrC |
| Georgia @_GeorgiaHurst RT @KathleenMaxian: This is good news, this patient population is desperate for new treatments! #gyncsm https://t.co/LQvXX3GLuz |
| Georgia @_GeorgiaHurst RT @womenofteal: #gyncsm https://t.co/noz3ZWcIfq |
| Georgia @_GeorgiaHurst RT @gyncsm: T3: T3: Which studies presented at the meeting will impact treatment of women with #endometrialcancer #uterinecancer #sarcoma? #gyncsm |
| Shereese Maynard, MS; MBA 😷 She/Her @ShereeseMayMba T2 With any of the studies, was there any results or data based on propensity scoring? #gyncsm |
| Tobey @BRCAinfo RT @ClearityFnd: T2: T2: From our Scientific Director, Dr. Deb Zajchowski, “Exciting preliminary results for PARP inhibitors combined with immune checkpoint inhibitors — particularly in platinum-resistant patients.” #gyncsm https://t.co/t8ZAnUU9zE |
| Shannon Westin, MD, MPH, FASCO @ShannonWestin T3: Excited re our study (in rodents) of everolimus-eluting IUD pres by @JDottinoMD - could allow pts to avoid surgery in endo ca #gyncsm |
| Dee Sparacio @womenofteal T3 #gyncsm @TaylorJolyn reported on this study #endometrial https://t.co/3dF3lIYTaS |
| Tobey @BRCAinfo RT @RieOfLetters: Excited to see these types of findings in more than one #research study. Hoping for continued progress! #gyncsm https://t.co/5X9ejWHHrC |
| GYN Cancer | #GYNCSM @gyncsm T4: What research on palliative care and survivorship do you think will impact patients lives the most - or that survivors should ask their gyn/onc's about? #gyncsm |
| Shereese Maynard, MS; MBA 😷 She/Her @ShereeseMayMba RT @gyncsm: T4: T4: What research on palliative care and survivorship do you think will impact patients lives the most - or that survivors should ask their gyn/onc's about? #gyncsm |
| Dee Sparacio @womenofteal #gyncsm https://t.co/JsjVCm8ybX |
| Georgia @_GeorgiaHurst RT @womenofteal: T3 #gyncsm @TaylorJolyn reported on this study #endometrial https://t.co/3dF3lIYTaS |
| Rick Boulay,MD @journeycancer Teeny tiny IUDs. #gyncsm https://t.co/Y3dpOeXy83 |
| Suzie Siegel @SuzieSiegel My friend Matt Anderson, MD, PhD, presented on the genomic profiling of #uterine #leiomyosarcoma from The Cancer Genome Atlas as well as his own lab in Baylor. Data from @ALazarMDPhD was included. This is bigly important for us. #gyncsm #TCGA |
| Georgia @_GeorgiaHurst RT @gyncsm: T4: T4: What research on palliative care and survivorship do you think will impact patients lives the most - or that survivors should ask their gyn/onc's about? #gyncsm |
| Christina Lizaso @btrfly12 RT @gyncsm: T4: T4: What research on palliative care and survivorship do you think will impact patients lives the most - or that survivors should ask their gyn/onc's about? #gyncsm |
| Suzie Siegel @SuzieSiegel This data confirmed gyn #leiomyosarcoma differs from LMS elsewhere. #gyncsm |
| Dee Sparacio @womenofteal T4 @Stigetta reported this from the meeting. #survivorship #gyncsm https://t.co/tl6BMHp35R |
| Christina Lizaso @btrfly12 #gyncsm |
| Dee Sparacio @womenofteal #gyncsm https://t.co/ayZqAXPQbg |
| Dee Sparacio @womenofteal RT @SuzieSiegel: My friend Matt Anderson, MD, PhD, presented on the genomic profiling of #uterine #leiomyosarcoma from The Cancer Genome Atlas as well as his own lab in Baylor. Data from @ALazarMDPhD was included. This is bigly important for us. #gyncsm #TCGA |
| Georgia @_GeorgiaHurst RT @womenofteal: T4 @Stigetta reported this from the meeting. #survivorship #gyncsm https://t.co/tl6BMHp35R |
| Georgia @_GeorgiaHurst RT @AndytweetM: Personalized vaccine for ovarian cancer. Dr.Coukos,most likely,will share this during his #AACR18 keynote #gyncsm #ImmunoOnc #Immunotherapy https://t.co/l5ytGuhFkN |
| Shereese Maynard, MS; MBA 😷 She/Her @ShereeseMayMba RT @womenofteal: T4 @Stigetta reported this from the meeting. #survivorship #gyncsm https://t.co/tl6BMHp35R |
| Jenny Mueller MD @JennyMueller_ T3: Exciting abstract on uterine serous cancers - improved response using trastuzumab plus carbo/taxol in Her2 overexpressed tumors. #gyncsm |
| Tobey @BRCAinfo RT @womenofteal: T4 @Stigetta reported this from the meeting. #survivorship #gyncsm https://t.co/tl6BMHp35R |
| Rick Boulay,MD @journeycancer There was a study that finally measured and estimated rates of post op lymphedema which were much higher than anticipated. If we can measure it we can look for ways to reduce it. #gyncsm https://t.co/NhXqOjdsDW |
| Dee Sparacio @womenofteal #gyncsm https://t.co/gjIEM5sHQf |
| Christina Lizaso @btrfly12 T4: Overall, I think it has been great to see an increase each year in survivorship studies and talk of long-term care planning and navigators/coordinators. Patients living longer and more emphasis on support. #gyncsm |
| Christina Lizaso @btrfly12 RT @womenofteal: T4 @Stigetta reported this from the meeting. #survivorship #gyncsm https://t.co/tl6BMHp35R |
| Dee Sparacio @womenofteal #gyncsm I remember a few tweets about this https://t.co/oOD3nSsr46 |
| Rick Boulay,MD @journeycancer RT @womenofteal: T4 @Stigetta reported this from the meeting. #survivorship #gyncsm https://t.co/tl6BMHp35R |
| Christina Lizaso @btrfly12 RT @journeycancer: There was a study that finally measured and estimated rates of post op lymphedema which were much higher than anticipated. If we can measure it we can look for ways to reduce it. #gyncsm https://t.co/NhXqOjdsDW |
| Dee Sparacio @womenofteal #gyncsm https://t.co/jsiMmLud7Z |
| Suzie Siegel @SuzieSiegel Drs. Martee Hensley (left) & Suzanne George, experts on #uterine #sarcoma, answered questions after presenting at a Research to Practice course. #gyncsm I felt so privileged to hear them both speak. https://t.co/ksVS1hcdOT |
| Jenny Mueller MD @JennyMueller_ @journeycancer so true! #gyncsm |
| Tobey @BRCAinfo Any studies on #Immunotherapy of interest? #gyncsm |
| Inspire @InspireIsHealth RT @Stigetta: Fantastic sunrise seminar on survivorship! Survivors need to be empowered with information after front line treatment. Reduce risk and screen for secondary cancers. #sgomtg #gyncsm https://t.co/OLyOW0E4lL |
| Christina Lizaso @btrfly12 @journeycancer I never read much about lymphedema in the pre-surgery literature for GYN cancer about what to expect. Always wondered about that. #gyncsm |
| Suzie Siegel @SuzieSiegel @journeycancer And gyn oncs need to remember that they don't have to take out lymph nodes in uterine #leiomyosarcoma unless the nodes appear diseased. #gyncsm |
| Jennifer N Stall, MD @JNStallMD @gyncsm I was not at SGO but results from the phase 2 trial looking at carbo/taxol vs carbo/tax + trastuzimab (herceptin) in uterine serous CA with Her2/neu overexpression were presented. Improved PFS w/addition of herceptin. Any1 have more info? #gyncsm |
| Christina Lizaso @btrfly12 @BRCAinfo and re: vaccines to prevent recurrence? #gyncsm |
| Georgia @_GeorgiaHurst @ShannonWestin @JDottinoMD #gyncsm Was there any mention of #Lynchsyndrome related cancers at SGO, and if so, what were the most recent, interesting findings? |
| Tobey @BRCAinfo RT @btrfly12: @BRCAinfo and re: @BRCAinfo and re: vaccines to prevent recurrence? #gyncsm |
| Dee Sparacio @womenofteal #gyncsm https://t.co/AlZy6ljyXQ |
| Rick Boulay,MD @journeycancer Lots. Many combinations and mono therapies. And it looked very favorable for stabilizing disease. #gyncsm https://t.co/6Vgz5uGuOA |
| GYN Cancer | #GYNCSM @gyncsm T5: Once again studies showed less gyn cancer clinical trials and lower funding for gyn cancer research. What suggestions were made to increase enrollment and funding? #gyncsm |
| Dee Sparacio @womenofteal RT @journeycancer: Lots. Many combinations and mono therapies. And it looked very favorable for stabilizing disease. #gyncsm https://t.co/6Vgz5uGuOA |
| Dee Sparacio @womenofteal #gyncsm https://t.co/3scra0btIa |
| Tobey @BRCAinfo @journeycancer I’m really excited about this #gyncsm |
| Shannon Westin, MD, MPH, FASCO @ShannonWestin T5: We MUST advocate for gynecologic cancer funding - write your Congressman and tell them that this funding must be INCREASED!! #gyncsm |
| Rie Lopez, MPH (she/her) @RieOfLetters RT @gyncsm: T5: T5: Once again studies showed less gyn cancer clinical trials and lower funding for gyn cancer research. What suggestions were made to increase enrollment and funding? #gyncsm |
| Georgia @_GeorgiaHurst RT @ShannonWestin: T5: T5: We MUST advocate for gynecologic cancer funding - write your Congressman and tell them that this funding must be INCREASED!! #gyncsm |
| Rie Lopez, MPH (she/her) @RieOfLetters RT @ShannonWestin: T5: T5: We MUST advocate for gynecologic cancer funding - write your Congressman and tell them that this funding must be INCREASED!! #gyncsm |
| Tobey @BRCAinfo RT @ShannonWestin: T5: T5: We MUST advocate for gynecologic cancer funding - write your Congressman and tell them that this funding must be INCREASED!! #gyncsm |
| Georgia @_GeorgiaHurst RT @gyncsm: T5: T5: Once again studies showed less gyn cancer clinical trials and lower funding for gyn cancer research. What suggestions were made to increase enrollment and funding? #gyncsm |
| Jenny Mueller MD @JennyMueller_ T5: we need to continue advocating for more funding! #gyncsm |
| Dee Sparacio @womenofteal #gyncsm Yes we must do this. https://t.co/gyjTcBKKcf |
| Christina Lizaso @btrfly12 RT @ShannonWestin: T5: T5: We MUST advocate for gynecologic cancer funding - write your Congressman and tell them that this funding must be INCREASED!! #gyncsm |
| Rick Boulay,MD @journeycancer Yes. In context of the use of checkpoint inhibitors. #gyncsm https://t.co/FK5biidDch |
| Clearity Foundation @ClearityFnd RT @gyncsm: T5: T5: Once again studies showed less gyn cancer clinical trials and lower funding for gyn cancer research. What suggestions were made to increase enrollment and funding? #gyncsm |
| Georgia @_GeorgiaHurst RT @journeycancer: Yes. In context of the use of checkpoint inhibitors. #gyncsm https://t.co/FK5biidDch |
| Jennifer N Stall, MD @JNStallMD @JennyMueller_ T3: Agree... exciting abstract. Several pre-analytical issues that can affect Her2 testing results which will be important to consider for the future #gyncsm |
| Clearity Foundation @ClearityFnd We agree! #gyncsm https://t.co/4CDXqu7Lib |
| Rick Boulay,MD @journeycancer MAKE SOME NOISE!!! Call your congressperson. #gyncsm https://t.co/INhsBZ9zEl |
| Dee Sparacio @womenofteal T5 #gyncsm the photo in this tweet shows how great the need is via @ShannonWestin https://t.co/1rWWaBrjJV |
| Shannon Westin, MD, MPH, FASCO @ShannonWestin T5: Outcomes are better for minorities who have access to #clinicaltrials - we need funding to ensure these trials are available #gyncsm |
| Shannon Westin, MD, MPH, FASCO @ShannonWestin RT @womenofteal: T5 #gyncsm the photo in this tweet shows how great the need is via @ShannonWestin https://t.co/1rWWaBrjJV |
| Rick Boulay,MD @journeycancer RT @womenofteal: T5 #gyncsm the photo in this tweet shows how great the need is via @ShannonWestin https://t.co/1rWWaBrjJV |
| Rick Boulay,MD @journeycancer RT @ShannonWestin: T5: T5: Outcomes are better for minorities who have access to #clinicaltrials - we need funding to ensure these trials are available #gyncsm |
| Clearity Foundation @ClearityFnd RT @womenofteal: T5 #gyncsm the photo in this tweet shows how great the need is via @ShannonWestin https://t.co/1rWWaBrjJV |
| Inspire @InspireIsHealth RT @ShannonWestin: Research for #ovariancancer #endometrialcancer and #cervicalcancer is grossly underfunded compared to #ProstateCancer - this is a disturbing trend for our patients. #SGOMtg #gyncsm https://t.co/NfqGNF1h1w |
| Rie Lopez, MPH (she/her) @RieOfLetters RT @womenofteal: T5 #gyncsm the photo in this tweet shows how great the need is via @ShannonWestin https://t.co/1rWWaBrjJV |
| Jenny Mueller MD @JennyMueller_ @A2Path hopefully issues that can be overcome. #gyncsm |
| Christina Lizaso @btrfly12 I thought this was an important study. #clinicaltrials are an important part of cancer care. Many in general population still think trials are last resort and consider them "experimental" in a very negative risky way. #gyncsm https://t.co/vSzpcEtZT8 |
| GYN Cancer | #GYNCSM @gyncsm We have several questions/thoughts out there - feel free to now add any additional tweets re: the latest gynecologic cancer research. #gyncsm |
| Dee Sparacio @womenofteal @btrfly12 @BRCAinfo #gyncsm Here is a link to a study reported at SGO on a vaccine to prevent recurrence in OC https://t.co/phQx2osDcN |
| GYN Cancer | #GYNCSM @gyncsm Links to @SGO_org #SGOMtg Abstracts: Abstracts https://t.co/WaMk2TKaED and https://t.co/1DsmvwXsfH #gyncsm |
| Dee Sparacio @womenofteal #gyncsm https://t.co/QyfVYyWTKU |
| Georgia @_GeorgiaHurst @journeycancer #gyncsm Can you please tell us a little more about check point inhibitors and what that they’re used for in regards to #Lynchsyndrome cancers, Dr. Boulay? 😉 |
| Tobey @BRCAinfo @womenofteal @btrfly12 🙏TYSVM 👍 #gyncsm |
| Georgia @_GeorgiaHurst RT @gyncsm: Links to @SGO_org #SGOMtg Abstracts: Links to @SGO_org #SGOMtg Abstracts: Abstracts https://t.co/WaMk2TKaED and https://t.co/1DsmvwXsfH #gyncsm |
| GYN Cancer | #GYNCSM @gyncsm #SGOmtg Coverage and Videos https://t.co/gElRX6TCYg compiled by @SGO_org #gyncsm |
| Dee Sparacio @womenofteal @Stigetta and @LilySue49 wrote this highlights article re SGO https://t.co/wkNfUN8w2k #gyncsm |
| Suzie Siegel @SuzieSiegel Still on #uterine #leiomyosarcoma: I'm glad the #sarcoma med oncs talked about the many lines of chemo -- I can think of at least 6 -- they might give. Some gyn oncs offer fewer. #gyncsm |
| Tobey @BRCAinfo RT @gyncsm: Links to @SGO_org #SGOMtg Abstracts: Links to @SGO_org #SGOMtg Abstracts: Abstracts https://t.co/WaMk2TKaED and https://t.co/1DsmvwXsfH #gyncsm |
| Clearity Foundation @ClearityFnd T5: From our Scientific Director, Dr. Deb Zajchowski, “We need more funding. We also need to get the word out to enroll in the many clinical trials that are already available. There are more than 300 #clinicaltrials that #ovariancancer patients can enter.” #gyncsm https://t.co/yVkQFeRCEw |
| Tobey @BRCAinfo RT @womenofteal: @btrfly12 @BRCAinfo #gyncsm Here is a link to a study reported at SGO on a vaccine to prevent recurrence in OC https://t.co/phQx2osDcN |
| Georgia @_GeorgiaHurst @gyncsm @SGO_org Thank you! #gyncsm |
| Shannon Westin, MD, MPH, FASCO @ShannonWestin @IAmGeorgiaHurst @journeycancer Right now - they are FDA approved for any tumor that has MSI (microsatellite instability) - that includes Lynch Syndrome assoc tumors #gyncsm |
| Georgia @_GeorgiaHurst RT @womenofteal: @btrfly12 @BRCAinfo #gyncsm Here is a link to a study reported at SGO on a vaccine to prevent recurrence in OC https://t.co/phQx2osDcN |
| Georgia @_GeorgiaHurst RT @gyncsm: We have several questions/thoughts out there - feel free to now add any additional tweets re: We have several questions/thoughts out there - feel free to now add any additional tweets re: the latest gynecologic cancer research. #gyncsm |
| Georgia @_GeorgiaHurst RT @btrfly12: I thought this was an important study. #clinicaltrials are an important part of cancer care. Many in general population still think trials are last resort and consider them "experimental" in a very negative risky way. #gyncsm https://t.co/vSzpcEtZT8 |
| Rie Lopez, MPH (she/her) @RieOfLetters It is essential that we include BIPOC in #clinicaltrials, to improve outcomes for all. However, funding is definitely lagging. Get involved in the fight for #gyncsm funding! #BreakthroughCrew https://t.co/ujy9DCH4zo |
| Georgia @_GeorgiaHurst RT @ShannonWestin: T5: T5: Outcomes are better for minorities who have access to #clinicaltrials - we need funding to ensure these trials are available #gyncsm |
| Tobey @BRCAinfo RT @gyncsm: #SGOmtg Coverage and Videos https://t.co/gElRX6TCYg compiled by @SGO_org #gyncsm |
| Shannon Westin, MD, MPH, FASCO @ShannonWestin RT @btrfly12: I thought this was an important study. #clinicaltrials are an important part of cancer care. Many in general population still think trials are last resort and consider them "experimental" in a very negative risky way. #gyncsm https://t.co/vSzpcEtZT8 |
| Dee Sparacio @womenofteal We're opening the floor to thoughts / questions / links #gyncsm https://t.co/1AvrvxW0si |
| Georgia @_GeorgiaHurst RT @ShannonWestin: @IAmGeorgiaHurst @journeycancer Right now - they are FDA approved for any tumor that has MSI (microsatellite instability) - that includes Lynch Syndrome assoc tumors #gyncsm |
| Rie Lopez, MPH (she/her) @RieOfLetters RT @ClearityFnd: T5: T5: From our Scientific Director, Dr. Deb Zajchowski, “We need more funding. We also need to get the word out to enroll in the many clinical trials that are already available. There are more than 300 #clinicaltrials that #ovariancancer patients can enter.” #gyncsm https://t.co/yVkQFeRCEw |
| Rick Boulay,MD @journeycancer I was very surprised that chemo for early stage endometrial Cancer didn’t improve outcomes. Especially after last years ASCO when it was discussed that it may replace radiation. #gyncsm |
| Tobey @BRCAinfo Oh we have lots of reading to do TY 💕 #gyncsm |
| Georgia @_GeorgiaHurst @ShannonWestin @journeycancer Thank you! #gyncsm |
| Jenny Mueller MD @JennyMueller_ @btrfly12 Great video to share (from SGO) on clinical trial basics! https://t.co/UWjBqxQ584 #gyncsm |
| Christina Lizaso @btrfly12 For #ovariancancer, see advocate summaries via @ocrfa https://t.co/q84N16ggPr and also @womenofteal blog https://t.co/d8GzDhyzwD #gyncsm |
| Tobey @BRCAinfo RT @RieOfLetters: It is essential that we include BIPOC in #clinicaltrials, to improve outcomes for all. However, funding is definitely lagging. Get involved in the fight for #gyncsm funding! #BreakthroughCrew https://t.co/ujy9DCH4zo |
| Rie Lopez, MPH (she/her) @RieOfLetters RT @JennyMueller_: @btrfly12 Great video to share (from SGO) on clinical trial basics! https://t.co/UWjBqxQ584 #gyncsm |
| Christina Lizaso @btrfly12 @JennyMueller_ Awesome, will share! #gyncsm |
| Tobey @BRCAinfo RT @btrfly12: For #ovariancancer, see advocate summaries via @ocrfa https://t.co/q84N16ggPr and also @womenofteal blog https://t.co/d8GzDhyzwD #gyncsm |
| Jennifer N Stall, MD @JNStallMD @JennyMueller_ Yes. Breast and gastric cancers have Her2 testing guidelines. So will be an area where such guidelines need to be formed or expanded to uterine serous CA if herceptin is to be utilized. #gyncsm |
| GYN Cancer | #GYNCSM @gyncsm RT @JennyMueller_: @btrfly12 Great video to share (from SGO) on clinical trial basics! https://t.co/UWjBqxQ584 #gyncsm |
| DaveisAliveAndKickn @AliveAndKicknDD RT @btrfly12: I thought this was an important study. #clinicaltrials are an important part of cancer care. Many in general population still think trials are last resort and consider them "experimental" in a very negative risky way. #gyncsm https://t.co/vSzpcEtZT8 |
| Georgia @_GeorgiaHurst RT @btrfly12: For #ovariancancer, see advocate summaries via @ocrfa https://t.co/q84N16ggPr and also @womenofteal blog https://t.co/d8GzDhyzwD #gyncsm |
| GYN Cancer | #GYNCSM @gyncsm RT @ClearityFnd: T5: T5: From our Scientific Director, Dr. Deb Zajchowski, “We need more funding. We also need to get the word out to enroll in the many clinical trials that are already available. There are more than 300 #clinicaltrials that #ovariancancer patients can enter.” #gyncsm https://t.co/yVkQFeRCEw |
| Georgia @_GeorgiaHurst RT @journeycancer: I was very surprised that chemo for early stage endometrial Cancer didn’t improve outcomes. Especially after last years ASCO when it was discussed that it may replace radiation. #gyncsm |
| Clearity Foundation @ClearityFnd Scientific Director, Dr. Deb Zajchowski knows that there are several advantages to enrolling in #clinicaltrials. However, only 5%-10% of patients enroll! What can we do to get those numbers up? #gyncsm |
| Michele E. Collins @Michele_w_1_L This was very informative. I look forward to the next one. Glad I stopped lurking and started participating! #gyncsm |
| GYN Cancer | #GYNCSM @gyncsm Thanks everyone for joining and sharing. Special thanks to those who attended SGO and shared. Next #gyncsm chat: Wed May 9th at 9pmET on Palliative Care - When and Why? with guest @ctsinclair #hpm |
| Dee Sparacio @womenofteal T6 glad to see some study of cost effectiveness via @DeannaTeoh #gyncsm https://t.co/MCJiS136QG |
| Tobey @BRCAinfo RT @gyncsm: Thanks everyone for joining and sharing. Special thanks to those who attended SGO and shared. Next #gyncsm chat: Thanks everyone for joining and sharing. Special thanks to those who attended SGO and shared. Next #gyncsm chat: Wed May 9th at 9pmET on Palliative Care - When and Why? with guest @ctsinclair #hpm |
| GYN Cancer | #GYNCSM @gyncsm Remember to tweet things of interest with hashtag #gyncsm to keep the conversation going between chats. |
| Georgia @_GeorgiaHurst @gyncsm @ctsinclair #gyncsm Thank you for the great and informative chat...sleep well, everyone! |
| Dee Sparacio @womenofteal @michelellen Thanks for joining . See you soon #gyncsm |
| Dee Sparacio @womenofteal #gyncsm https://t.co/k3F3gAkUdN |
| Dee Sparacio @womenofteal #gyncsm https://t.co/CsDNSnr2lm |
| Clearity Foundation @ClearityFnd Over 25% of women who have come to @ClearityFnd over the years have enrolled in #clinicaltrials! Check out our new guided trial finder: https://t.co/p8PdJNYUvS #gyncsm |
| Georgia @_GeorgiaHurst RT @JennyMueller_: @btrfly12 Great video to share (from SGO) on clinical trial basics! https://t.co/UWjBqxQ584 #gyncsm |
| Tobey @BRCAinfo TY #gyncsm for another great chat & all that you do. 👏👏👏 |
| Dee Sparacio @womenofteal Grateful for our #gyncsm co-moderators! @btrfly12 @ShannonWestin @DrMarkham @journeycancer @DrBeckerSchutte #gyncsm |
| Christina Lizaso @btrfly12 RT @ClearityFnd: Scientific Director, Dr. Deb Zajchowski knows that there are several advantages to enrolling in #clinicaltrials. However, only 5%-10% of patients enroll! What can we do to get those numbers up? #gyncsm |
| Rick Boulay,MD @journeycancer Essentially the MMR in LS makes the cells more susceptible to attack by the immune cells. The checkpoint inhibitors allow the immune system to be more effective. https://t.co/IgYmJdlXLx #gyncsm https://t.co/9lLOedEz4o |
| Tobey @BRCAinfo RT @womenofteal: Grateful for our #gyncsm co-moderators! @btrfly12 @ShannonWestin @DrMarkham @journeycancer @DrBeckerSchutte #gyncsm |
| Dee Sparacio @womenofteal May 8th is World Ovarian Cancer Day ( #WOCD) for more information see https://t.co/kQvQTCbaX7 follow them at @OvarianCancerDY #gyncsm |
| Shannon Westin, MD, MPH, FASCO @ShannonWestin Another great #gyncsm is in the books! Thanks @womenofteal and @btrfly12 |
| Christina Lizaso @btrfly12 @IAmGeorgiaHurst Thanks for all you do and for your support. Sweet dreams :) #gyncsm |
| Rick Boulay,MD @journeycancer RT @ClearityFnd: T5: T5: From our Scientific Director, Dr. Deb Zajchowski, “We need more funding. We also need to get the word out to enroll in the many clinical trials that are already available. There are more than 300 #clinicaltrials that #ovariancancer patients can enter.” #gyncsm https://t.co/yVkQFeRCEw |
| Dee Sparacio @womenofteal Remember to check https://t.co/Df2f7Okp35 for a transcript of the chat and resources #gyncsm |
| Suzie Siegel @SuzieSiegel One last thing: I'm not going to SGO next year in Hawaii -- that's too expensive. At some point, we'll have to talk about the cost of patient attendance at conferences. #gyncsm |
| Dee Sparacio @womenofteal @ShannonWestin @btrfly12 Thanks for joining and for tweeting from the meeting so we could stay on top of the latest news. #gyncsm |
| Dee Sparacio @womenofteal @IAmGeorgiaHurst @gyncsm @ctsinclair Thanks. great to have you back. #gyncsm |
| Tobey @BRCAinfo RT @womenofteal: May 8th is World Ovarian Cancer Day ( #WOCD) for more information see https://t.co/kQvQTCbaX7 follow them at @OvarianCancerDY #gyncsm |
| Christina Lizaso @btrfly12 RT @womenofteal: Remember to check https://t.co/Df2f7Okp35 for a transcript of the chat and resources #gyncsm |
| Christina Lizaso @btrfly12 RT @womenofteal: May 8th is World Ovarian Cancer Day ( #WOCD) for more information see https://t.co/kQvQTCbaX7 follow them at @OvarianCancerDY #gyncsm |
| Rick Boulay,MD @journeycancer RT @womenofteal: Grateful for our #gyncsm co-moderators! @btrfly12 @ShannonWestin @DrMarkham @journeycancer @DrBeckerSchutte #gyncsm |
| Dee Sparacio @womenofteal @SuzieSiegel Agreed. I can cover advocagte registration fee - it's the travel expenses and hotel that break the bank for me. #gyncsm |
| Christina Lizaso @btrfly12 RT @journeycancer: Essentially the MMR in LS makes the cells more susceptible to attack by the immune cells. The checkpoint inhibitors allow the immune system to be more effective. https://t.co/IgYmJdlXLx #gyncsm https://t.co/9lLOedEz4o |
| Rick Boulay,MD @journeycancer RT @womenofteal: Grateful for our #gyncsm co-moderators! @btrfly12 @ShannonWestin @DrMarkham @journeycancer @DrBeckerSchutte #gyncsm |
| Dee Sparacio @womenofteal Thanks everyone who joined in tonight and those who followed along. Appreciate you taking the time to share with our community. #gyncsm |
| Jennifer N Stall, MD @JNStallMD @journeycancer What types did this study look at? Carcinomas or sarcomas? #gyncsm |
| Rick Boulay,MD @journeycancer I think a lot of Clinicsl and research folks feel the same. #gyncsm https://t.co/l1vqGcChNj |
| Christina Lizaso @btrfly12 RT @womenofteal: @btrfly12 @BRCAinfo #gyncsm Here is a link to a study reported at SGO on a vaccine to prevent recurrence in OC https://t.co/phQx2osDcN |
| Dee Sparacio @womenofteal @btrfly12 Thanks for keeping us on track and as always for taking thoughts and crafting them into great questions. #gyncsm |
| Dee Sparacio @womenofteal RT @gyncsm: Thanks everyone for joining and sharing. Special thanks to those who attended SGO and shared. Next #gyncsm chat: Thanks everyone for joining and sharing. Special thanks to those who attended SGO and shared. Next #gyncsm chat: Wed May 9th at 9pmET on Palliative Care - When and Why? with guest @ctsinclair #hpm |
| Rick Boulay,MD @journeycancer That was fun. Good night everyone. #gyncsm |
| Dee Sparacio @womenofteal Patients and caregivers are invited to continue our discussion on the Smart Patients platform at https://t.co/CwNPWNrWjY #gyncsm |
| Dee Sparacio @womenofteal Read more about #gyncsm working w/ @smart_patients to continue our chats in >private setting w/ >140 characters https://t.co/a6yEF1DSlD #gyncsm |
| Christina Lizaso @btrfly12 @journeycancer Thanks so much. Sweet dreams. #gyncsm |
| Georgia @_GeorgiaHurst RT @journeycancer: Essentially the MMR in LS makes the cells more susceptible to attack by the immune cells. The checkpoint inhibitors allow the immune system to be more effective. https://t.co/IgYmJdlXLx #gyncsm https://t.co/9lLOedEz4o |
| Dee Sparacio @womenofteal We have talented #gyncsm healthcare moderators, Hope your concert is a success @journeycancer https://t.co/DSdrnWOsFM |
| Rick Boulay,MD @journeycancer Will be performing at @NOCC_National National Meeting in April in NYC. Hope to see you! #gyncsm https://t.co/hMxutNvQjY |
| Christina Lizaso @btrfly12 RT @womenofteal: We have talented #gyncsm healthcare moderators, Hope your concert is a success @journeycancer https://t.co/DSdrnWOsFM |
| Christina Lizaso @btrfly12 RT @journeycancer: Will be performing at @NOCC_National National Meeting in April in NYC. Hope to see you! #gyncsm https://t.co/hMxutNvQjY |
| Jennifer N Stall, MD @JNStallMD @journeycancer Applying molecular stratification may be revealing at some point. #gyncsm |
 | Hello_U👋🏼 @MommysCancer #Dogs #smell #breastcancer #ovariancancer #lungcancer #prostatecancer #thyroidcancer #colorectalcancer #melanoma #bcsm #gyncsm #lcsm https://t.co/N7hYkW1lOI |
#GynCSM content from Twitter.